This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. You shall have music wherever you go. The new MPC Sample is a fully portable devices for ...
Despite its slightly toy-like looks, the MPC Sample is a fast and fun machine that channels the spirit of its early-'90s predecessors. Fun, fast workflow reminiscent of classic MPCs. Chopping and ...
Introduction: The clinical assessment of patients with ataxias requires reliable scales. We aimed to translate, adapt and validate the International Cooperative Ataxia Rating Scale (ICARS) into ...
Correspondence to Professor Nobuhiro Yuki, Department of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine, 14 Medical Drive, Singapore 117599, Singapore; ...
Please provide your email address to receive an email when new articles are posted on . The Revoice uses ultra-sensitive sensors and artificial intelligence to decode physical and emotional cues. The ...
A soft, wearable neck device that translates silent throat muscle vibrations into audible speech was associated with improved communication fluency and higher patient satisfaction among stroke ...
Speech impairment, known as dysarthria, is a very common consequence of strokes, affecting nearly half of all survivors. A stroke can cause weakness in the facial muscles and vocal cords, making it ...
Researchers have developed a wearable, comfortable and washable device called Revoice that could help people regain the ability to communicate naturally and fluently following a stroke, without the ...
Researchers have developed a wearable, comfortable and washable device called Revoice that could help people regain the ability to communicate naturally and fluently following a stroke, without the ...
Introduction Dysarthria is one of the most prevalent communication disorders following a stroke, and it can lead to social isolation and depression, significantly hindering rehabilitation progress.
Please provide your email address to receive an email when new articles are posted on . Approximately 5,000 people in the United States have Friedreich’s ataxia. Advocates virtually met with ...
PTC Therapeutics has long been trying to workshop its vatiquinone into a marketable treatment for Friedreich's ataxia (FA) after a phase 3 fail in 2023. Despite its efforts, the FDA has snubbed the ...